Related Experiment Video
Updated: May 23, 2026
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
[Statin-ezetimibe combination in hyperlipidemia treatment]
Tomás Vareka1, Daniela Vítková, Miroslav Zeman
1Univerzita Karlova v Praze, 1. lékarská fakulta, IV. Interní klinika VFN, Praha. vareka.t@seznam.cz
Casopis Lekaru Ceskych
|March 27, 2012
Summary
Adding ezetimibe to statin therapy significantly lowers cholesterol and triglycerides in patients with severe dyslipidemia. This combination therapy is safe and effective, helping more patients reach their lipid targets.
Area of Science:
- Cardiology
- Endocrinology
- Pharmacology
Background:
- Statin monotherapy often fails to achieve lipid targets in dyslipidemia.
- Combining statins with ezetimibe presents a viable treatment strategy.
- Severe dyslipidemia requires effective therapeutic options.
Purpose of the Study:
- To evaluate the efficacy and safety of statin plus ezetimibe combination therapy.
- To assess treatment outcomes in patients with severe dyslipidemia in a lipid and diabetology setting.
Main Methods:
- Retrospective analysis of 82 dyslipidemia patients over 3 months.
- Ezetimibe 10 mg/day added to existing statin therapy.
- Subgroup analysis included 26 patients with type 2 diabetes.
Main Results:
- Significant reductions observed in total cholesterol (-21%), LDL-C (-28%), and triglycerides (-26%).
- Recommended LDL-C targets achieved in 42% of all patients and 48% of diabetics.
- No significant adverse effects were reported during the treatment period.
Conclusions:
- Ezetimibe addition to statins effectively lowers LDL-C and total cholesterol.
- Combination therapy improves achievement of target lipid values.
- Statin-ezetimibe combination is a safe and effective treatment for hyperlipidemia.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
01:26Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...